Skip to content
  • Portfolio
  • About us
  • News
  • Contact us

News & Press

Investment

Abselion raises £6.6 million led by M Ventures

December 4, 2024
News

Martin Bloom joins NG Bio’s Board of Directors

November 25, 2024
Investment

LightOx raises £1.5m to develop oral cancer preventative treatment

June 13, 2024
Investment

Mesenbio raises £1.4M to develop therapeutic pipeline

January 9, 2024
Investment

Bastion Therapeutics secures financing to develop advanced Treg therapeutics

September 12, 2023
Exit

Molecular Devices adds proprietary patient-derived organoid technology with acquisition of Cellesce

December 6, 2022
Investment

Abselion (at the time HexagonFab) secures $2.6m seed funding to launch the Bolt

April 20, 2021

Social

Breakthrough cures for chronic diseases

    • © 2024 NG Bio
    • Made by Original people

    NG Bio Ltd is an appointed representative of Midmar Capital LLP, which is authorised and regulated by the Financial Conduct Authority, in respect of UK investment advisory or arranging activities. | Risk Summary